JPRN-UMIN000002381已完成2 期
Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancer - NHO0501
ational Hospital Study Group for Lung Cancer0 个研究点目标入组 65 人开始时间: 2009年8月26日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Infections 2.Apparent interstitial pneumonitis or fibrosis on chest CT 3.Irradiation field larger than half of a ipsilateral lung 4.Ileus 5.Neuropathy (motor, sensory) 6.Severe complications(liver cirrhosis, diabetes mellitus, Clinically significant heart disease, etc.) 7.Myocardial infarction within the last 6 months 8.Another active cancer 9.Pregnancy, intent to become pregnant, or breast-feeding 10.Other non eligible cases judged by investigators
研究者
相似试验
已完成
1 期
A phase I/II trial of concurrent thoracic radiotherapy with the combination of cisplatin and nab-pacliaxel for locally advanced non-small cell lung cancerlocally advanced non-small cell lung cancerJPRN-UMIN000012531Department of Medical Oncology, Kindai University, Faculty of Medicine25
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
进行中(未招募)
1 期
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsEUCTR2016-003468-38-FRCentre François baclesse
已完成
2 期
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
已完成
2 期
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70
